Other OTC - Delayed Quote USD

Ayala Pharmaceuticals, Inc. (ADXS)

0.5720 +0.0020 (+0.35%)
At close: April 19 at 1:47 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
13.0000
13.0000
692.0000
3,506.0000
3,708.0000
Cost of Revenue
13.0000
13.0000
602.0000
3,506.0000
3,708.0000
Gross Profit
--
--
90.0000
--
--
Operating Expense
36,266.0000
36,266.0000
37,593.0000
39,218.0000
29,777.0000
Operating Income
-36,266.0000
-36,266.0000
-37,503.0000
-39,218.0000
-29,777.0000
Net Non Operating Interest Income Expense
-15,718.0000
-15,718.0000
74.0000
-260.0000
56.0000
Pretax Income
-51,984.0000
-51,984.0000
-37,429.0000
-39,478.0000
-29,721.0000
Tax Provision
-3,912.0000
-3,912.0000
584.0000
776.0000
425.0000
Net Income Common Stockholders
-48,072.0000
-48,072.0000
-38,013.0000
-40,254.0000
-30,146.0000
Diluted NI Available to Com Stockholders
-48,072.0000
-48,072.0000
-38,013.0000
-40,254.0000
-30,146.0000
Basic EPS
-7.99
-7.99
-13.13
-2.80
-3.06
Diluted EPS
-7.99
-7.99
-13.13
-2.80
-3.06
Basic Average Shares
6,019.0630
6,019.0630
2,895.1300
14,398.9050
9,860.6100
Diluted Average Shares
6,019.0630
6,019.0630
2,895.1300
14,398.9050
9,860.6100
Total Operating Income as Reported
-36,266.0000
-36,266.0000
-37,503.0000
-39,218.0000
-29,777.0000
Total Expenses
36,279.0000
36,279.0000
38,195.0000
42,724.0000
33,485.0000
Net Income from Continuing & Discontinued Operation
-48,072.0000
-48,072.0000
-38,013.0000
-40,254.0000
-30,146.0000
Normalized Income
-48,072.0000
-48,072.0000
-38,013.0000
-40,254.0000
-30,146.0000
Interest Income
28.0000
28.0000
74.0000
--
56.0000
Interest Expense
15,746.0000
15,746.0000
--
260.0000
--
Net Interest Income
-15,718.0000
-15,718.0000
74.0000
-260.0000
56.0000
EBIT
-36,238.0000
-36,238.0000
-37,429.0000
-39,218.0000
-29,777.0000
EBITDA
-35,869.0000
-35,869.0000
-37,267.0000
-39,050.0000
-29,595.0000
Reconciled Cost of Revenue
13.0000
13.0000
602.0000
3,506.0000
3,708.0000
Reconciled Depreciation
369.0000
369.0000
162.0000
168.0000
182.0000
Net Income from Continuing Operation Net Minority Interest
-48,072.0000
-48,072.0000
-38,013.0000
-40,254.0000
-30,146.0000
Normalized EBITDA
-35,869.0000
-35,869.0000
-37,267.0000
-39,050.0000
-29,595.0000
Tax Rate for Calcs
0.0001
0.0001
0.0002
0.0002
0.0002
12/31/2020 - 5/8/2020
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

TRAW Traws Pharma, Inc.
0.6700
-2.33%
 
HEPA Hepion Pharmaceuticals, Inc.
2.0100
-1.95%
 
OTLC Oncotelic Therapeutics, Inc.
0.0394
-6.19%
 
ASLN ASLAN Pharmaceuticals Limited
0.5120
-5.19%
 
CNBX CNBX Pharmaceuticals Inc.
0.0114
+9.62%
 
ATHXQ Athersys, Inc.
0.0045
+36.36%
 
AURX Nuo Therapeutics, Inc.
0.8000
0.00%
 
CPMV Mosaic ImmunoEngineering, Inc.
0.4020
+22.25%
 
WINT Windtree Therapeutics, Inc.
0.3418
+2.15%
 
ARDS Aridis Pharmaceuticals, Inc.
0.0600
-2.48%